Kochav Defense Acquisition Corp.
NASDAQ:KCHVInvestment - Banking & Investment Services
-$0.04 today
- Market cap
- $359.70M
- Beta
- 0.01
- P/E (TTM)
- 49.6
- EPS (TTM)
- $0.21
Volume 0.00M
Average 0.02M
KCHV Total Debt
Short-term and long-term borrowings combined.
Kochav Defense Acquisition Corp.NASDAQ: KCHV
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt remains negative
Q1 FY2026 total debt was $0, compared with $45.42K a year earlier.
Context
- Total debt amounted to 0.0% of total assets at the end of Q1 FY2026, down 69.4 pp from a year earlier.
What to watch
Whether total debt keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
Currency unavailable · from the balance sheet
No Total Debt data reported for this period type.
Total Debt vs competitors
How KCHV compares with its peers on the latest reported figures
- KCHV's Mar 2026 total debt of $0 is the lowest of the 2 companies compared; the peer median is $25.98M.
- Its year-over-year change of -100.0% is the lowest of 2, against a peer median of -10.3%.
- Total debt amounts to 0.0% of total assets for KCHV, versus a peer median of 1.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $25.98M | -10.3% | +17.3% | 1.0% | |
KCHVKochav Defense Acquisition Corp. | Mar 2026 | $0 | -100.0% | — | 0.0% |
| Peer median (excluding KCHV) | $25.98M | -10.3% | +17.3% | 1.0% | |
Competitors are the stored peer set for KCHV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Kochav Defense Acquisition Corp.
NASDAQ:KCHV
Intrinsic Alpha fair value
Locked
Current Price
$10.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.